v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 4,088 $ 9,521
Prepaid expenses and other current assets 41 399
Total current assets 4,129 9,920
Long-term restricted cash 10 10
Other long-term assets 13
Total assets 4,139 9,943
Current liabilities:    
Accounts payable 272 809
Accrued expenses and other current liabilities 57 120
Total current liabilities 329 929
Warrant liability 67
Total liabilities 329 996
Commitments and contingencies (Note 9)  
Stockholders’ equity:    
Preferred stock, $0.0001 par value - 500,000 shares authorized; 6,746 shares designated Series A convertible preferred stock; no shares issued and outstanding at December 31, 2025 and 2024
Common stock, $0.0001 par value - 200,000,000 shares authorized; 3,652,285 shares issued and outstanding at December 31, 2025 and 2024
Additional paid-in capital 306,128 306,103
Accumulated deficit (302,318) (297,156)
Total stockholders’ equity 3,810 8,947
Total liabilities and stockholders’ equity $ 4,139 $ 9,943